Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (“SCT”) announced today that Dr. Brett Schonekess, VP Operations, will be presenting a company overview and information about NTxTM-265, the companies lead program in stroke, at the 12th Annual Bio-Europe conference on Wednesday, November 8th, 2006. The conference is being held in Duesseldorf, Germany from November 6-8, 2006.
